 Home > Active Ingredient News > Digestive System Information > FDA granted fast track qualification for IL-5 inhibitor Fasenra (benarizumab) for the treatment of eosinophilic gastritis (EG)

FDA granted fast track qualification for IL-5 inhibitor Fasenra (benarizumab) for the treatment of eosinophilic gastritis (EG)

 Last Update: 2021-12-03
 Source: Internet
 Author: User

Tags

fast food

drug overdose videos

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Eosinophilic gastrointestinal disorder (EGID) is a collective term for a group of diseases, including eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), and Eosinophilic gastroenteritis (eosinophilic gastroenteritis, EGE), eosinophilic enteritis and eosinophilic colitis (eosinophilic colitis, EC)
.

In patients with eosinophilic gastritis and eosinophilic gastroenteritis, excess eosinophils can cause a variety of potentially debilitating gastrointestinal symptoms, including abdominal pain, vomiting, and diarrhea

FDA

Since EG/EGE is relatively rare, there are not many data on its prevalence
.

According to previous survey data, the prevalence of EGE in the United States is estimated to be 22/100,000

Recently, AstraZeneca IL-5 inhibitors Fasenra (Tony Canary natalizumab) has received US Food and Drug Administration fast-track designation Bureau, for the treatment of eosinophilic gastritis (EG), with or without Eosinophilic gastroenteritis (EGE)
.

The biological therapy has also received orphan drug designation from the FDA for the treatment of EG and EGE

manage

AZ is launching a phase III clinical trial called HUDSON to evaluate the efficacy and safety of Fasenra in patients with EG and/or EGE
.

AZ is launching a phase III clinical trial called HUDSON to evaluate the efficacy and safety of Fasenra in patients with EG and/or EGE

Blood vessel

Original source:

https:// href="https://" target="_blank" rel="noopener">https:// https:// Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Raw Material Powder 99% White Powder CAS 474-25-9 Chenodeoxycholic Acid

CAS No.: 474-25-9

Pharmacy Grade

$4-5/G FOB

Highest Quality CAS 119141-88-7 Esomeprazole powder 99% in Stock Fast Delivery

CAS No.: 119141-88-7

Pharmacy Grade

$4-5/G FOB

Wholesale Magnesium Oxide Raw Materials CAS 1309-48-4 99% Powder Evergreen EGC-Magnesium Oxide Powder

CAS No.: 1309-48-4

Food Grade

$70-76/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.